The strong CD8+T cell response post-TBEV infection raised the question as to whether next-generation mRNA vaccines, proven to boost cellular immunity in immunodeficient patients [49], should also be employed for TBE, potentially benefiting those with XLA and other hypogammaglobulinemic disorders. Here, CD8A is linked to tick-borne encephalitis.